Improved long-term outcomes after renal transplantation associated with blood pressure control

被引:211
作者
Opelz, G [1 ]
Döhler, B [1 ]
机构
[1] Heidelberg Univ, Inst Immunol, Dept Transplantat Immunol, D-6900 Heidelberg, Germany
关键词
Blood pressure control; hypertension; long-term transplant outcomes; renal transplantation;
D O I
10.1111/j.1600-6143.2005.01093.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hypertension has a negative impact on long-term outcomes after renal transplantation. We investigated the effect of a recent decline in blood pressure among renal transplant patients in the Collaborative Transplant Study (CTS) database on long-term graft and patient survival. CTS data were used to evaluate transplant outcomes in relation to recipient systolic blood pressure (SBP) for 24 404 first cadaver kidney recipients transplanted between 1987 and 2000. Patients whose SBP was > 140 mmHg at 1 year posttransplantation but controlled to <= 140 mmHg by 3 years had significantly improved long-term graft outcome compared with patients with sustained high SBP to 3 years (RR 0.79; CI 0.73--0.86; p < 0.001). Additional examination at 5 years showed that SBP lowering after year 3 was associated with improved 10-year graft survival (RR 0.83; CI 0.72-0.96; p = 0.01), whereas even a temporary increase in SBP at 3 years was associated with worse survival (RR 1.37; CI 1.19-1.58; p < 0.001). Changes in SBP were paralleled by changes in the incidence of cardiovascular death among recipients younger than 50 but not in older recipients. Lowering SBP, even after several years of posttransplantation hypertension, is associated with improved graft and patient survival in renal allograft recipients.
引用
收藏
页码:2725 / 2731
页数:7
相关论文
共 20 条
[1]
2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension [J].
Afridi, I ;
Canny, J ;
Yao, CH ;
Christensen, B ;
Cooper, RS ;
Kadiri, S ;
Hill, S ;
Kaplan, N ;
Kuschnir, E ;
Lexchin, J ;
Mendis, S ;
Poulter, N ;
Psaty, BM ;
Rahn, KH ;
Sheps, SG ;
Whitworth, J ;
Yach, D ;
Bengoa, R ;
Ramsay, L ;
Kaplan, N ;
Mendis, S ;
Poulter, N ;
Whitworth, J .
JOURNAL OF HYPERTENSION, 2003, 21 (11) :1983-1992
[2]
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy [J].
Barnett, AH ;
Bain, SC ;
Bouter, P ;
Karlberg, B ;
Madsbad, S ;
Jervell, J ;
Mustonen, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (19) :1952-1961
[3]
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[4]
The renal protective effects of angiotensin II receptor blockers in type 2 diabetes mellitus [J].
Coyle, JD ;
Gardner, SF ;
White, CM .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (10) :1731-1738
[5]
[6]
Long-term kidney transplant survival [J].
Hariharan, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (06) :S44-S50
[7]
Kasiske BL, 2000, SEMIN NEPHROL, V20, P176
[8]
Hypertension after kidney transplantation [J].
Kasiske, BL ;
Anjum, S ;
Shah, R ;
Skogen, J ;
Kandaswamy, C ;
Danielson, B ;
O'Shaughnessy, EA ;
Dahl, DC ;
Silkensen, JR ;
Sahadevan, M ;
Snyder, JJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (06) :1071-1081
[9]
Blood pressure and end-stage renal disease in men [J].
Klag, MJ ;
Whelton, PK ;
Randall, BL ;
Neaton, JD ;
Brancati, FL ;
Ford, CE ;
Shulman, NB ;
Stamler, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (01) :13-18
[10]
Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8